Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.
about
Lipid mediators in the resolution of inflammationThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolutionResolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actionsRoles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbuminNovel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?A rare adult case of poststreptococcal acute glomerulonephritis with a retropharyngeal abscess.Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationSpecific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsTranscriptional regulation of 15-lipoxygenase expression by histone h3 lysine 4 methylation/demethylationLipoxins as biomarkers of lupus and other inflammatory conditionsChemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.Resolvins and protectins in inflammation resolution.Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammationObesity, immunomodulation and chronic kidney disease.Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.Lipoxins: resolutionary road.Resolution of inflammation: targeting GPCRs that interact with lipids and peptides.Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.Re-Examining Neutrophil Participation in GN.Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome.Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II
P2860
Q28250668-1B4CD4F4-FF5F-4490-9F49-5C071DCA70BAQ28260186-2B7C68DD-396B-408E-B8B1-E3EE5F9D1076Q28264433-643435A3-5E9D-43A4-A3C1-5677268BC158Q28394575-1942C405-439B-490E-8E95-1D074D695AD4Q33683210-3082828B-1653-4432-A5FD-F640442EF9AAQ33710316-B3B875A8-F1D0-48DF-BBCE-67B03F182BECQ34157528-1D998B6D-39F3-471F-BB07-5ADE3B92ECA8Q34294883-318353ED-EDD5-440A-A75F-F92FA5DC631CQ34534477-DFCBB33B-C2AA-4A5A-9AF5-CD8E46DE44ADQ35044584-F66DE4E3-4C65-4A21-963D-AF14CE663C14Q35069540-CB32D083-CD71-4FF1-86CB-B930D30427DCQ35170024-2D2FF029-714F-4BAF-B1A0-B1F21BC44F9CQ35332873-5E03FA0A-8676-4B07-9D30-C729AA73C4FFQ35557372-BB2ED8D3-015D-46C2-9C0C-CFF89034923DQ35640634-492D4887-2D91-44DD-904D-CF2D2FCD2B56Q36461242-9D7B5435-7E1C-462F-8ECE-98DE91C4E050Q37604436-94752FFD-63B2-45CB-9EC7-6634876F9B8CQ38226022-7F585C88-AC0D-4B2F-A226-B22F59E0E003Q39024419-845237F9-1BB2-4022-AF7C-1CAB33E493F7Q39163938-FD66C14D-2263-4B09-BCE5-9FAC898149FFQ39376963-23583583-4116-4D81-8F82-376E4039D7D4Q40162059-A6C45AF8-E2F4-4DAF-9EB8-40561F1BB924Q41205365-C18B989B-2D14-4FA9-9CBB-6AA5E15455FFQ41672237-6FA174B5-AB4C-4A2D-A130-3106ABF53FC6Q52583506-8F4D5E0F-6BFC-40A2-AAC1-C9FBDA91164CQ56699408-E4066DF1-AEB7-4584-A7C6-BE71D2417783
P2860
Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@en
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@nl
type
label
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@en
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@nl
prefLabel
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@en
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@nl
P2093
P2860
P1476
Elevated expressions of 15-lip ...... eptococcal glomerulonephritis.
@en
P2093
Pei-Ling Yin
Pei-Yuan Liao
Sheng-Hua Wu
Yong-Mei Zhang
P2860
P304
P356
10.2353/AJPATH.2009.080671
P407
P577
2008-12-18T00:00:00Z